[Effect of dalargin on systolic pressure in chronic experimental disorders of cardiovascular regulation].
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D002908:Chronic Disease; D004353:Drug Evaluation, Preclinical; D004743:Enkephalin, Leucine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016308:Enkephalin, Leucine-2-Alanine / Q000031:analogs & derivatives*; D006978:Hypertension, Renovascular / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D009200:Myocardial Contraction / Q000187:drug effects*; D051381:Rats; D012078:Renal Artery Obstruction / Q000188:drug therapy / Q000503:physiopathology; D013315:Stress, Psychological / Q000188:drug therapy* / Q000503:physiopathology; D013599:Systole / Q000187:drug effects*
D004743:Enkephalin, Leucine; D016308:Enkephalin, Leucine-2-Alanine; C040996:enkephalin-Leu, Ala(2)-Arg(6)-
Vliianie dalargina na sistolicheskoe davlenie pri éksperimental'nykh khronicheskikh narusheniiakh serdechno-sosudistoĭ reguliatsii.